Literature DB >> 6165306

Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages.

R B Herberman, J R Ortaldo, J Y Djeu, H T Holden, J Jett, N P Lang, M Rubinstein, S Pestka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6165306     DOI： 10.1111/j.1749-6632.1980.tb20608.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  12 in total

1.  Effects of recombinant leukocyte interferon on serum immunoglobulin concentrations and lymphocyte subpopulations in chronic hepatitis B.

Authors:  H Tsuji; K Murai; K Akagi; M Fujishima
Journal:  J Clin Immunol       Date:  1990-01       Impact factor: 8.317

Review 2.  Natural killer activity: early days, advances, and seminal observations.

Authors:  John R Ortaldo; Robert H Wiltrout; Craig W Reynolds
Journal:  Crit Rev Oncog       Date:  2014

3.  Effects of ultraviolet irradiation on natural killer cell function in systemic lupus erythematosus.

Authors:  O Nived; I Johansson; G Sturfelt
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

4.  Lysis of small cell carcinoma of the lung tumor cell lines by gamma interferon-activated allogeneic peripheral blood mononuclear cells: abrogation of killing by pretreatment of tumor cells with gamma interferon.

Authors:  E D Ball; K E Nichols; O S Pettengill; G D Sorenson; M W Fanger
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Influence of human interferon-alpha therapy on cytotoxic functions of blood lymphocytes. Studies on lectin-dependent cellular cytotoxicity, antibody-dependent cellular cytotoxicity, and natural killer cell activity.

Authors:  S Einhorn; H Blomgren; H Strander; J Wasserman
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF).

Authors:  E Kedar; B L Ikejiri; E Gorelik; R B Herbermann
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

7.  Phase-I trial of UltrapureTM human leukocyte interferon in human malignancy.

Authors:  G T Budd; R M Bukowski; L Miketo; B Yen-Lieberman; M R Proffitt
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

8.  A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients.

Authors:  S Shiozawa; K Chihara; K Shiozawa; T Fujita; H Ikegami; S Koyama; M Kurimoto
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

9.  Cellular suppression of murine ADCC and NK activities induced by Corynebacterium parvum.

Authors:  V K Milisauskas; G Cudkowicz; I Nakamura
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  The binding of insulin to mouse leucocytes during viral infections.

Authors:  F Shimizu; C R Kahn; C Garzelli; J J Hooks; A L Notkins
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.